Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson’s disease: a Bayesian network meta-analysis

Key Points

• Quality of life improves with MAO-B and COMT inhibitors in Parkinson's disease patients, confirming their potential benefits.
• Bayesian network meta-analysis indicates significant improvement in quality of life through specific treatments.
• Analysis compares multiple studies, synthesizing evidence around the effectiveness of MAO-B and COMT inhibitors.
• Findings may inform future treatment strategies for managing Parkinson's disease-related symptoms.

Abstract